LeMaitre Vascular Balance Sheet Health
Financial Health criteria checks 6/6
LeMaitre Vascular has a total shareholder equity of $319.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $363.1M and $43.5M respectively. LeMaitre Vascular's EBIT is $45.6M making its interest coverage ratio -11.5. It has cash and short-term investments of $113.1M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -11.5x |
| Cash | US$113.10m |
| Equity | US$319.53m |
| Total liabilities | US$43.55m |
| Total assets | US$363.08m |
Recent financial health updates
No updates
Recent updates
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Financial Position Analysis
Short Term Liabilities: LMAT's short term assets ($212.8M) exceed its short term liabilities ($25.4M).
Long Term Liabilities: LMAT's short term assets ($212.8M) exceed its long term liabilities ($18.1M).
Debt to Equity History and Analysis
Debt Level: LMAT is debt free.
Reducing Debt: LMAT had no debt 5 years ago.
Debt Coverage: LMAT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: LMAT has no debt, therefore coverage of interest payments is not a concern.